Accelr8 Technology Corp (AMEX:AXK)
| CAPS Rating |
|
|---|---|
| Open | $1.40 |
| Previous Close | $1.36 |
| Daily Range | $1.37 - $1.44 |
| 52-Week Range | $1.02 - $7.80 |
| Market Cap | $14.76M |
| P/E Ratio | 15.60 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 13,679 |
| Average Daily Volume | 0 |
AXK
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
AXK Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
Related News and Articles
- Illuminating the Way Forward for Genomics – The Motley Fool
- Life Technologies' Sequence of Success – The Motley Fool
- Has Sequenom Become the Perfect Stock? – The Motley Fool
- Hang Tight: This Bid Will Increase – The Motley Fool
- Amass a Fortune With These Stocks – The Motley Fool
- Amass a Fortune With These Stocks – The Motley Fool
- The Promise and Peril of the Mass-Market Genome – The Motley Fool
- Is Life Technologies' Stock Cheaper Than Its 20 P/E Ratio? – The Motley Fool
- Can Varian's Stock Be Cheap by the Numbers? – The Motley Fool
- Another Entry in the Genome Patent Rumble – The Motley Fool
- Is Bruker's Growth for Real? – The Motley Fool
- Why the Street Should Love Life Technologies' Earnings – The Motley Fool
- How Cheap Is Waters' Stock by the Numbers? – The Motley Fool
- Checking Illumina's Growth – The Motley Fool
- Don't Get Too Worked Up Over ICON's Earnings – The Motley Fool
- Is Illumina's Stock Expensive or Cheap by the Numbers? – The Motley Fool
- Why Thermo Fisher Scientific May Be About to Take Off – The Motley Fool
- The Race to the $1,000 Genome – The Motley Fool
- Are You Watching This Trend at Life Technologies? – The Motley Fool
- Why Luminex May Be About to Take Off – The Motley Fool
RSS Headlines
Fool UK
